Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Given the associations between chronic inflammation and epithelial cancer, we studied susceptibility to skin carcinogenesis in mice deficient for the pro-inflammatory cytokine TNF-alpha (refs. 5,6). TNF-alpha(-/-) mice were resistant to development of benign and malignant skin tumors, whether induced by initiation with DMBA and promotion with TPA or by repeated dosing with DMBA. TNF-alpha(-/-) mice developed 5-10% the number of tumors developed by wild-type mice during initiation/promotion and 25% of those in wild-type mice after repeated carcinogen treatment. TNF-alpha could influence tumor and stromal cells during tumor development. The early stages of TPA promotion are characterized by keratinocyte hyperproliferation and inflammation. These were diminished in TNF-alpha(-/-) mice. TNF-alpha was extensively induced in the epidermis, but not the dermis, in TPA-treated wild-type skin, indicating that dermal inflammation is controlled by keratinocyte TNF-alpha production. Deletion of a TNF-alpha inducible chemokine also conferred some resistance to skin tumor development. TNF-alpha has little influence on later stages of carcinogenesis, as tumors in wild-type and TNF-alpha(-/-) mice had similar rates of malignant progression. These data provide evidence that a pro-inflammatory cytokine is required for de novo carcinogenesis and that TNF-alpha is important to the early stages of tumor promotion. Strategies that neutralize TNF-alpha production may be useful in cancer treatment an…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MCP1 is a critical chemoattractant responsible for the recruitment of macrophages into tumor and for angiogenesis in breast cancer [131, 132], and may contribute to indirect crosstalk between MSC and cancer cells via recruitment of tumor-resident macrophages.”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [132]
Citations
Cites
Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker
Bradley, P. P., Priebat, D. A., Christensen, R. D., & Rothstein, G. (1982) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12506462 · Cited by 3,626
Correa, P. (1992) · PubMed · Cited by 3,216
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,218
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
Self-citationLu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Self-citationEggermont, A. M., Schraffordt Koops, H., Liénard, D., Kroon, B. B., van Geel, A. N., Hoekstra, H. J., & Lejeune, F. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2653 · Cited by 398
Genetic Polymorphisms in the Tumor Necrosis Factor Locus Influence Non-Hodgkin's Lymphoma Outcome
Warzocha, K., Ribeiro, P., Bienvenu, J., Roy, P., Charlot, C., Rigal, D., Coiffier, B., & Salles, G. (1998) · Blood · doi:10.1182/blood.v91.10.3574 · Cited by 272
Naylor, M. S., Stamp, G. W., Foulkes, W. D., Eccles, D., & Balkwill, F. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116446 · Cited by 252
Self-citationAnti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis
Feldmann, M., Elliott, M. J., Maini, R. N., & Woody, J. N. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60891-3 · Cited by 230
Pasparakis, M., Alexopoulou, L., Grell, M., Pfizenmaier, K., Bluethmann, H., & Kollias, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6319 · Cited by 205
Self-citation
Cited by
Items 401–500 of 838
Complement System in Cutaneous Squamous Cell Carcinoma
Riihilä, P., Nissinen, L. M., Knuutila, J. S., Nezhad, P. R., Viiklepp, K., & Kähäri, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143550 · Cited by 52
Curran, J. A., Laverty, F. S., Campbell, D., MacDiarmid, J. A., & Wilson, J. B. (2001) · PubMed · Cited by 43
Context-dependent roles for lymphotoxin-β receptor signaling in cancer development
Fernandes, M. T., Dejardin, E., & dos Santos, N. R. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.02.005 · Cited by 50
Rigby, C. M., Roy, S., Deep, G., Guillermo-Lagae, R., Jain, A., Dhar, D., Orlicky, D. J., Agarwal, C., & Agarwal, R. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw106 · Cited by 51
Ho, G., Xue, X., Burk, R. D., Kaplan, R. C., Cornell, E. S., & Cushman, M. (2005) · Cytokine · doi:10.1016/j.cyto.2004.08.008 · Cited by 44
The role of PGE2-associated inflammatory responses in gastric cancer development
Oshima, H., & Oshima, M. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0353-5 · Cited by 44
Khan, M. F., Anwer, T., Bakht, M. A., Verma, G., Akhtar, W., Alam, M. M., Rizvi, M. M. A., Akhter, M., & Shaquiquzzaman, M. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.03.071 · Cited by 43
Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis
Li, X., & Hu, Y. (2021) · Cancers · doi:10.3390/cancers13061411 · Cited by 47
Mechanistic Insights into the Link between Obesity and Prostate Cancer
Adesunloye, B. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083935 · Cited by 47
MK2 regulates the early stages of skin tumor promotion
Johansen, C., Vestergaard, C., Kragballe, K., Kollias, G. A., Gaestel, M., & Iversen, L. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp238 · Cited by 44
Self-citationThe effect of cyclooxygenase‐2 overexpression on skin carcinogenesis is context dependent
Rundhaug, J. E., Pavone, A., Kim, E., & Fischer, S. M. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20340 · Cited by 41
THERAPEUTIC RELEVANCE OF ALTERED CYTOKINE EXPRESSION
Kulmatycki, K. M., & Jamali, F. (2001) · Cytokine · doi:10.1006/cyto.2000.0827 · Cited by 41
Regulatory T Cells and Cancer: A Two-Sided Story
Wang, K., & Vella, A. T. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1197242 · Cited by 46
In vivo single-cell CRISPR uncovers distinct TNF programmes in tumour evolution
Renz, P. F., Ghoshdastider, U., Baghai Sain, S., Valdivia-Francia, F., Khandekar, A., Ormiston, M., Bernasconi, M., Duré, C., Kretz, J. A., Lee, M., et al. (2024) · Nature · doi:10.1038/s41586-024-07663-y · Cited by 40
Kumamoto, H., & Ooya, K. (2005) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2005.00311.x · Cited by 44
Tentori, L., Muzi, A., Dorio, A. S., Bultrini, S., Mazzon, E., Lacal, P. M., Shah, G. M., Zhang, J., Navarra, P., Nocentini, G., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.03.019 · Cited by 40
CXCR3 Enhances a T-Cell–Dependent Epidermal Proliferative Response and Promotes Skin Tumorigenesis
Winkler, A. E., Brotman, J. J., Pittman, M. E., Judd, N. P., Lewis, J. S., Schreiber, R. D., & Uppaluri, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0907 · Cited by 42
A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma
Larkin, J., Ferguson, T., Pickering, L. M., Edmonds, K., James, M. G., Thomas, K., Banerji, U., Berns, B., de Boer, C., & Gore, M. E. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605889 · Cited by 40
Modulation of CD4 T Cell Response According to Tumor Cytokine Microenvironment
Accogli, T., Bruchard, M., & Végran, F. (2021) · Cancers · doi:10.3390/cancers13030373 · Cited by 45
Yamada, M., Yanaba, K., Hasegawa, M., Matsushita, Y., Horikawa, M., Komura, K., Matsushita, T., Kawasuji, A., Fujita, T., Takehara, K., et al. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02989.x · Cited by 41
p85α Acts as a Novel Signal Transducer for Mediation of Cellular Apoptotic Response to UV Radiation
Song, L., Li, J., Ye, J., Yu, G., Ding, J., Zhang, D., Ouyang, W., Dong, Z., Kim, S. O., & Huang, C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00657-06 · Cited by 42
TNF‐α stimulates Akt by a distinct aPKC‐dependent pathway in premalignant keratinocytes
Faurschou, A., & Gniadecki, R. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00740.x · Cited by 40
Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis
Zur, R., Garcia‐Ibanez, L., Nuñez-Buiza, Á., Aparicio, N., Liappas, G., Escós, A., Risco, A., Page, A., Sáiz-Ladera, C., Alsina‐Beauchamp, D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4320 · Cited by 39
Tagami, K., Niwa, K., Lian, Z., Gao, J., Mori, H., & Tamaya, T. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.156 · Cited by 39
van Hogerlinden, M., Rozell, B. L., Toftgård, R., & Sundberg, J. P. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22706.x · Cited by 46
TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation
Atretkhany, K. N., Nosenko, M. A., Gogoleva, V. S., Zvartsev, R. V., Qin, Z., Nedospasov, S. A., & Drutskaya, M. S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00147 · Cited by 43
Ji, Y., Wang, Z., Li, Z., Zhang, A., Jin, Y., Chen, H., & Le, X. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445602 · Cited by 39
Modeling Cutaneous Squamous Carcinoma Development in the Mouse
Huang, P., & Balmain, A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a013623 · Cited by 51
Zhao, Y., Lv, J., Zhang, H., Xie, J., Zhang, X., & Hui, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.665442 · Cited by 37
Shi, G., & Hu, Y. (2023) · Cancers · doi:10.3390/cancers15174299 · Cited by 38
Wang, W., Guo, M., Hu, L., Cai, J., Zeng, Y., Luo, J., Shu, Z., Li, W., & Huang, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.399923 · Cited by 41
Yoshimura, T., Imamichi, T., Weiss, J. M., Sato, M., Li, L., Matsukawa, A., & Wang, J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00002 · Cited by 41
TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation
Chio, I. I. C., Sasaki, M., Ghazarian, D., Moreno, J. C. A., Done, S. J., Ueda, T., Inoue, S., Chang, Y., Chen, N., & Mak, T. W. (2012) · Nature Cell Biology · doi:10.1038/ncb2496 · Cited by 46
Karabela, S. P., Kairi, C. A., Magkouta, S., Psallidas, I., Moschos, C., Stathopoulos, I., Zakynthinos, S. G., Roussos, C., Kalomenidis, I., & Stathopoulos, G. T. (2011) · Neoplasia · doi:10.1593/neo.111224 · Cited by 38
Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
Sobo-Vujanovic, A., Vujanovic, L. N., DeLeo, A. B., Concha‐Benavente, F., Ferris, R. L., Lin, Y., & Vujanović, N. L. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0104 · Cited by 39
Sangaletti, S., Tripodo, C., Ratti, C., Piconese, S., Porcasi, R., Salcedo, R., Trinchieri, G., Colombo, M. P., & Chiodoni, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0471 · Cited by 38
Liu, C., Wong, Y., Chang, K., Chang, H., Liu, H., & Lee, Y. (2005) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2005.00359.x · Cited by 36
Khan, A. Q., Khan, R., Tahir, M., Rehman, M. U., Lateef, A., Ali, F., Hamiza, O. O., Hasan, S. K., & Sultana, S. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2014.863365 · Cited by 36
Banday, M. Z., Balkhi, H. M., Hamid, Z., Aga, S. S., Chowdri, N. A., & Haq, E. (2016) · Meta Gene · doi:10.1016/j.mgene.2016.06.001 · Cited by 43
Antitumor necrosis factor-α therapy and potential cancer inhibition
Williams, G. M. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3282b6fcff · Cited by 36
DeCicco-Skinner, K. L., Trovato, E. L., Simmons, J. K., Lepage, P. K., & Wiest, J. S. (2010) · Oncogene · doi:10.1038/onc.2010.447 · Cited by 40
Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-κB pathway
Feng, G., Ohmori, Y., & Chang, P. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi174 · Cited by 39
Chemical Carcinogens as Foreign Bodies and Some Pitfalls Regarding Cancer Immune Surveillance
Blankenstein, T. J. F., & Qin, Z. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)90006-6 · Cited by 38
Calogero, R., Cordero, F., Forni, G., & Cavallo, F. (2007) · Breast Cancer Research · doi:10.1186/bcr1745 · Cited by 35
Cheng, S. M., Xing, B., Li, J., Cheung, B. K. W., & Lau, A. S. Y. (2007) · International Journal of Cancer · doi:10.1002/ijc.22729 · Cited by 35
EVER2 protein binds TRADD to promote TNF-α-induced apoptosis
Gaud, G., Guillemot, D., Jacob, Y., Fãvre, M., & Vuillier, F. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.27 · Cited by 36
Aziz, M. H., Wheeler, D. L., Bhamb, B., & Verma, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2684 · Cited by 34
Menicali, E., Moretti, S., Voce, P., Romagnoli, S., Avenia, N., & Puxeddu, E. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00067 · Cited by 37
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice
Conti, L., Ruiu, R., Barutello, G., Macagno, M., Bandini, S., Cavallo, F., & Lanzardo, S. (2014) · BioMed Research International · doi:10.1155/2014/534969 · Cited by 43
Winterfield, L. S., & Menter, A. (2004) · Dermatologic Therapy · doi:10.1111/j.1396-0296.2004.04044.x · Cited by 46
Yang, J.-P., Hyun, M.-H., Yoon, J.-M., Park, M.-J., Kim, D., & Park, S. S. (2014) · Cytokine · doi:10.1016/j.cyto.2014.07.005 · Cited by 34
Siebenhaar, F., Metz, M., & Maurer, M. (2014) · Experimental Dermatology · doi:10.1111/exd.12328 · Cited by 34
HZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary Carcinogenesis
Barcellos-Hoff, M. H., & Mao, J.-H. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00057 · Cited by 34
Inflammation and Skin Cancer: Old Pals Telling New Stories
Hensler, S., & Mueller, M. M. (2013) · The Cancer Journal · doi:10.1097/ppo.0000000000000010 · Cited by 39
Dual Role of TNF and LTα in Carcinogenesis as Implicated by Studies in Mice
Gubernatorova, E. O., Polinova, A. I., Petropavlovskiy, M., Namakanova, O. A., Medvedovskaya, A. D., Zvartsev, R. V., Telegin, G. B., Drutskaya, M. S., & Nedospasov, S. A. (2021) · Cancers · doi:10.3390/cancers13081775 · Cited by 34
Luo, X., Liu, M., Hu, L., Qiu, Q., Liu, X., Li, C., Lu, M., Liu, Y., Zhang, T., Zhou, S., et al. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.06.021 · Cited by 35
Page, T. J., MacWilliams, P. S., Suresh, M., Jefcoate, C. R. E., & Czuprynski, C. J. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.02.014 · Cited by 34
Tumor necrosis factor α stimulates invasion of Src-activated intestinal cells
Kawai, N., Tsuji, S., Tsujii, M., Ito, T., Yasumaru, M., Kakiuchi, Y., Kimura, A., Komori, M., Sasaki, Y., Hayashi, N., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.31023 · Cited by 35
Varela, L. M., Stangle‐Castor, N. C., Shoemaker, S. F., Shea-Eaton, W. K., & Ip, M. M. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1103 · Cited by 34
Harberts, E. M., Heitmiller, K., & Gaspari, A. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_13 · Cited by 33
Differential inflammatory response to acrylonitrile in rat primary astrocytes and microglia
Caito, S. W., Yu, Y., & Aschner, M. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.02.006 · Cited by 37
Chiechi, A., Novello, C., Magagnoli, G., Petricoin, E. F., Deng, J., Benassi, M. S., Picci, P., Vaisman, I. I., Espina, V. A., & Liotta, L. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3416 · Cited by 36
Tripsianis, G., Papadopoulou, E. G., Romanidis, Κ., Katotomichelakis, M., Anagnostopoulos, K., Kontomanolis, E. N., Botaitis, S., Tentes, I. K., & Kortsaris, A. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.11.6813 · Cited by 42
Myeloid-derived suppressor cells and proinflammatory cytokines as targets for cancer therapy
Атретханы, К.-С. Н., & Drutskaya, M. S. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916110055 · Cited by 36
Tumor necrosis factor, lymphotoxin and cancer
Drutskaya, M. S., Efimov, G. A., Kruglov, A., Kuprash, D. V., & Nedospasov, S. A. (2010) · IUBMB Life · doi:10.1002/iub.309 · Cited by 40
Identification of a carcinoembryonic antigen binding protein on monocytes
Ganguly, A., Yeltsin, E., & Robbins, J. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.213 · Cited by 33
Waterston, A. M., Salway, F., Andreakos, E., Butler, D., Feldmann, M., & Coombes, R. C. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601670 · Cited by 35
Murakami, A., Takahashi, D., Hagihara, K., Koshimįzu, K., & Ohigashi, H. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.1056 · Cited by 33
Millán, O., Rico, D., Peinado, H., Zarich, N., Stamatakis, K., Pérez‐Sala, D., Rojas, J. M., Cano, A., & Boscá, L. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi213 · Cited by 38
Potential of p38 MAP kinase inhibitors in the treatment of cancer
Schultz, R. M. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8012-1_2 · Cited by 35
M1 macrophages – unexpected contribution to tumor progression
Kovaleva, O. V., Rashidova, M. A., Sinyov, V. V., Malashenko, O. S., & Gratchev, A. N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1638102 · Cited by 37
Development of a TNF-α-mediated Trojan Horse for bacteria-based cancer therapy
Hu, C.-W., Chang, Y.-C., Liu, C.-H., Yu, Y., & Mou, Y. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.04.008 · Cited by 36
Liu, X., Wu, W., Fang, L., Liu, Y., & Chen, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.922782 · Cited by 37
Anezaki, Y., Ohshima, S., Ishii, H., Kinoshita, N., Dohmen, T., Kataoka, E., Sato, W., Iizuka, M., Goto, T., Sasaki, J., et al. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00494.x · Cited by 37
Bernert, H., Sekikawa, K., Radcliffe, R. A., Iraqi, F. A., You, M., & Malkinson, A. M. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10151 · Cited by 32
Edwards, C. K., Bendele, A. M., Reznikov, L. L., Fantuzzi, G., Chlipala, E. S., Li, L., Moldawer, L. L., Mountz, J. D., Li, Y. Y., & Dinarello, C. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22077 · Cited by 33
Deng, S., Wang, S., Shi, X., & Zhou, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168940 · Cited by 37
Leibold, J., Riehl, A., Hettinger, J., Durben, M., Heß, J., & Angel, P. E. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.185 · Cited by 31
Association of TNF-α-308 and -238 Polymorphisms with Risk of Cervical Cancer: A Meta-analysis
Pan, F., Tian, J., Ji, C., He, Y., Han, X., Wang, Y., Du, J., Jiang, F., Zhang, Y., Pan, Y.-Y., et al. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.11.5777 · Cited by 31
Yoshimura, T., Liu, M., Chen, X., Li, L., & Wang, J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00332 · Cited by 32
Kanda, Y., Osaki, M., & Okada, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040867 · Cited by 39
Das, L., & Vinayak, M. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.889824 · Cited by 33
Kim, J., Son, J. E., Jang, Y. J., Lee, D.-E., Kang, N. J., Jung, S. K., Heo, Y., Lee, K. W., & Lee, H. J. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179200 · Cited by 32
Pérez, C. J., Mecklenburg, L., Jaubert, J., Martínez‐Santamaría, L., Iritani, B. M., Espejo, A. B., Napoli, E., Song, G., Río, M. D., DiGiovanni, J., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.314 · Cited by 30
Scheuer, C., Pommergaard, H., Rosenberg, J., & Gögenür, I. (2013) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12080 · Cited by 36
S100A9 has a protective role in inflammation‐induced skin carcinogenesis
McNeill, E., & Hogg, N. (2014) · International Journal of Cancer · doi:10.1002/ijc.28725 · Cited by 31
Ribeiro, O. G., Cabrera, W. H. K., Maria, D. A., Franco, M. D., Massa, S., Pace, R. F. D., de Souza, V. R. C., Starobinas, N., Semen, M., & Ibañez, O. M. (2004) · Experimental Lung Research · doi:10.1080/01902140490495237 · Cited by 29
Son, I. S., Lee, J. S., Lee, J., & Kwon, C. S. (2014) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2014.19.2.082 · Cited by 31
Walker, S. L., & Young, A. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703385104 · Cited by 32
Zou, H., Zhan, S.-X., & Cao, K.-M. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.12.010 · Cited by 30
Yoo, S., Park, J.-H., Hwang, S.-H., Oh, S., Lee, S., Cicatiello, V., Rho, S., Falco, S. D., Hwang, D., Cho, C., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402900 · Cited by 29
Williams, K. C., Gault, A., Anderson, A. E., Stewart, C. J., Lamb, C. A., Speight, R. A., Rajan, N., Plummer, R., & Pratt, A. G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1122430 · Cited by 28
Faurschou, A., Gniadecki, R., Calay, D., & Wulf, H. C. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.19 · Cited by 29
Tannic acid mitigates the DMBA/croton oil-induced skin cancer progression in mice
Majed, F., Rashid, S., Khan, A. Q., Nafees, S., Ali, N., Ali, R., Khan, R., Hasan, S. K., Mehdi, S. J., & Sultana, S. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2248-3 · Cited by 31
Benbrook, D. M., Lightfoot, S. A., Ranger‐Moore, J., Liu, T., Chengedza, S., Berry, W. L., & Dozmorov, I. M. (2008) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s344 · Cited by 28
Honda, A., Abe, R., Yoshihisa, Y., Makino, T., Matsunaga, K., Nishihira, J., Shimizu, H., & Shimizu, T. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp160 · Cited by 29
Predictors of psychological distress in breast cancer survivors: A biopsychosocial approach
Pérez-Tejada, J., Labaka, A., Pascual‐Sagastizábal, E., Garmendia, L., Iruretagoyena, A., & Arregi, A. (2019) · European Journal of Cancer Care · doi:10.1111/ecc.13166 · Cited by 37
Inhibitor-κB Kinase in Tumor Promotion and Suppression During Progression of Squamous Cell Carcinoma
Waes, C. V., Yu, M., Nottingham, L. K., & Karin, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1287 · Cited by 33
Wheeler, D. L., Li, Y., & Verma, A. K. (2005) · Photochemistry and Photobiology · doi:10.1562/2004-08-12-ra-271.1 · Cited by 30
Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy
Ma, Y., Yamazaki, T., Yang, H., Kepp, O., Galluzzi, L., Zitvogel, L., Smyth, M. J., & Kroemer, G. (2013) · OncoImmunology · doi:10.4161/onci.24786 · Cited by 27
Metadata
- Authors
- Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., Kollias, G., & Balkwill, F.
- Affiliations
- Hammersmith Hospital (GB)
- Harvard University (US)
- Pasteur Hellenic Institute (GR)
- Corresponding author
- Balkwill, Frances
- ORCID
- Venue
- Nature Medicine
- Published
- 1999-07
- Volume
- 5
- Issue
- 7
- Pages
- 828-831
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1585093254
- Cited by
- 839
- References
- 21
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 8 · 2023: 20 · 2022: 15 · 2021: 19 · 2020: 26 · 2019: 18 · 2018: 16 · 2017: 19 · 2016: 37 · 2015: 32 · 2014: 46 · 2013: 44 · 2012: 41
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- TNF-α, skin carcinogenesis, TNF-alpha knockout mice, tumor promotion, 7,12-dimethylbenz(a)anthracene, tissue plasminogen activator, keratinocyte hyperproliferation, skin inflammation, chemokines, malignant progression, chronic inflammation and cancer, cancer prevention
- MeSH terms
- Animals, Crosses, Genetic, Female, Immunity, Innate, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Inbred Strains, Neoplasm Invasiveness, Neoplasm Staging, Skin, Skin Neoplasms, Tetradecanoylphorbol Acetate, Time Factors, Tumor Necrosis Factor-alpha, 9,10-Dimethyl-1,2-benzanthracene, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.